share_log

Shattuck Labs | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(15.001%),Abigail P. Johnson(15.001%)

SEC announcement ·  Feb 9 09:57
Summary by Moomoo AI
FMR LLC has filed an amended Schedule 13G, disclosing a 15.001% ownership stake in Shattuck Labs, Inc. This amendment, dated February 8, 2024, represents a passive investment position by FMR LLC and its subsidiaries. The filing indicates that FMR LLC has sole power to dispose of or direct the disposition of 7,071,174 shares of common stock in Shattuck Labs. Abigail P. Johnson, as the CEO and Chairman of FMR LLC, along with other members of the Johnson family, may be deemed to have a controlling influence over FMR LLC due to their ownership of voting shares and a shareholders' voting agreement. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Shattuck Labs. The principal executive offices of Shattuck Labs are located at 500 W. 5th Street, Austin, TX 78701, USA.
FMR LLC has filed an amended Schedule 13G, disclosing a 15.001% ownership stake in Shattuck Labs, Inc. This amendment, dated February 8, 2024, represents a passive investment position by FMR LLC and its subsidiaries. The filing indicates that FMR LLC has sole power to dispose of or direct the disposition of 7,071,174 shares of common stock in Shattuck Labs. Abigail P. Johnson, as the CEO and Chairman of FMR LLC, along with other members of the Johnson family, may be deemed to have a controlling influence over FMR LLC due to their ownership of voting shares and a shareholders' voting agreement. The filing asserts that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing the control of Shattuck Labs. The principal executive offices of Shattuck Labs are located at 500 W. 5th Street, Austin, TX 78701, USA.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more